Two leading drugs in phase III clinical trial

  Several pharmaceutical companies are currently developing drugs that target Alzheimer’s disease. Developping a new drug takes years, and until now, no therapeutic has been able to thwart the development of the disease. But there is hope. Two leading drugs are currently undergoing stage 3 clinical trials. This is the last step prior to commercialization. … Continue reading Two leading drugs in phase III clinical trial